학술논문

Liver enzyme normalization predicts success of Hepatitis C oral direct-acting antiviral treatment.
Document Type
Journal Article
Source
Clinical & Investigative Medicine. Mar2017, Vol. 40 Issue 2, pE73-E80. 8p. 3 Charts, 2 Graphs.
Subject
*LIVER enzymes
*HEPATITIS C treatment
*ANTIVIRAL agents
*TREATMENT effectiveness
*UNIVARIATE analysis
*HEPATITIS C
*HEPATITIS viruses
*LIVER
*ORAL drug administration
*RNA
Language
ISSN
0147-958X
Abstract
Purpose: Monitoring of hepatitis C virus (HCV) treatment response is performed by serial HCV RNA measurements; however, this may not be useful for predicting treatment success or failure with oral direct-acting antiviral agent (DAA) therapies. Liver enzyme levels, which are elevated in chronic HCV and tend to decline on therapy, may serve as a more logistically and economically feasible alternative for monitoring treatment response.Source: The Ottawa Hospital Viral Hepatitis Clinic patients (n=219), receiving interferon-free oral DAA treatments, were assessed for liver enzymes and HCV RNA levels at baseline, week 4 and ≥12 weeks post-treatment. Suppression cut points used for this analysis were ALT ≤ 40U L-1 and AST ≤ 30U L-1. The primary outcome was week 12 sustained virologic response (SVR). By our analysis, all indicators had strong PPV (>90%) but limited NPV (. [ABSTRACT FROM AUTHOR]